Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-glucan pattern recognition receptors (PRRs) are a specialized class of immune receptors, with Dectin-1 (CLEC7A) being the most prominent member, that specifically recognize and bind to β-glucans found in fungal and bacterial cell walls (UniProt: Q9BXN2). These receptors are primarily expressed on myeloid cells, including macrophages, dendritic cells, and neutrophils, where they play a critical role in the innate immune system's ability to detect pathogens (PubMed: 16751776). Upon ligand binding, these receptors initiate signaling cascades involving the Syk kinase and CARD9 adapter protein, resulting in phagocytosis, respiratory burst, and the secretion of cytokines like IL-6 and IL-23 (PubMed: 19536192). In the context of disease, they are vital for defense against fungal infections and have been explored as targets for cancer immunotherapy to "re-educate" the immune system to attack tumor cells (PubMed: 21978437). Therapeutic strategies often involve using β-glucan polymers as agonists to enhance immune surveillance or modulate inflammatory responses in conditions like inflammatory bowel disease (PubMed: 28515777). These receptors also cooperate with other PRRs, such as Toll-like receptors, to fine-tune the immune response (PubMed: 12501250).
Agonistic binding to the receptor (primarily Dectin-1) triggers intracellular signaling via the Syk-CARD9 pathway, leading to the activation of NF-κB and the production of pro-inflammatory cytokines and reactive oxygen species to enhance host defense or anti-tumor immunity (PubMed: 19536192, PubMed: 21978437).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-glucan pattern recognition receptor (β-glucan PRR) (β-glucan PRR).